News > Serum Institute to apply for emergency licence for Covishield vaccine in next 2 weeks
Serum Institute to apply for emergency licence for Covishield vaccine in next 2 weeks
E-News | 28/11/2020 10:22 PM | Click to read full article
Adar Poonwalla, Chief Executive Officer of Serum Institute of India (SII), on November 28 said the vaccine maker is in the process of applying for emergency use licensure for its COVID-19 vaccine candidate Covishield in next two weeks.
On Novavax COVID-19 vaccine, which SII will be manufacturing and distributing in India and other markets, Poonawalla said the vaccine is 2-3 months behind Covishield.